SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                   FORM 10-Q/A

                                (Amendment No. 2)

(Mark One)
[X]  Quarterly  Report  Pursuant  to  Section  13 or 15(d)  of the  Securities
     Exchange Act of 1934. For the quarterly period ended September 30, 1997.

                                                         or

[ ]  Transition   Report  Pursuant  to  Section  13  or 15(d) of the  Securities
     Exchange   Act  of   1934.   For   the   Transition   period   from   to  .
     ------------------- -------------------


Commission File Number:  0-19671

                             LASERSIGHT INCORPORATED
                             -----------------------
             (Exact name of registrant as specified in its charter)


         Delaware                                          65-0273162
         --------                                          ----------
(State of Incorporation)                       (IRS Employer Identification No.)



                 12161 Lackland Road, St. Louis, Missouri 63146
                 ----------------------------------------------
               (Address of principal executive offices) (Zip Code)

                                 (314) 469-3220
                -----------------------------------------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.


Yes   X            No
    ----              ----


         The Number of shares of the registrant's Common Stock outstanding as of
November 13, 1997 is 9,984,672.


<PAGE>



                                EXPLANATORY NOTE

The filing amends certain  previously-filed  information  contained in Part II.,
Item 1. No other items have been amended.


                    LASERSIGHT INCORPORATED AND SUBSIDIARIES

Except for the historical  information  contained herein, the discussion in this
Report contains forward-looking statements (within the meaning of Section 21E of
the Exchange Act) that involve  risks and  uncertainties.  The Company's  actual
results could differ  materially from those  discussed here.  Factors that could
cause or contribute to such differences  include,  but are not limited to, those
discussed  in the sections  entitled  "Management's  Discussion  and Analysis of
Financial Condition and Results of Operations Uncertainties and Other Issues" in
this report and in the  Company's  Annual Report on Form 10-K for the year ended
December 31, 1996.


                                      INDEX
                                                                          


PART II.    OTHER INFORMATION

            Item 1.     Legal Proceedings                  




<PAGE>



                           PART II - OTHER INFORMATION

ITEM 1   LEGAL PROCEEDINGS

         Pillar Point Partners
         ---------------------

         On March 25, 1997,  the Company  entered into an agreement  with Pillar
         Point Partners and each co-plaintiff to resolve this litigation.  Under
         the agreement,  Pillar Point Partners and each  co-plaintiff  granted a
         release from  liability  under any of their  patents for certain of the
         Company's  ultraviolet laser corneal surgery systems and any service or
         procedure  performed with such systems before the effective date of the
         agreement.  The Company  paid a nominal fee in April 1997 and agreed to
         notify Pillar Point Partners and the  co-plaintiffs  before  LaserSight
         begins manufacturing or selling in the United States in the future. The
         action was dismissed  without  prejudice in the United States  District
         Court for the District of Delaware on March 26, 1997.

         VISX
         ----

         On May 27,  1997,  the Company  entered into a License  Agreement  with
         VISX,  Incorporated  to settle this  litigation  as well as any and all
         potential claims related to patent  infringement  prior to May 1, 1997.
         The  agreement  calls for an  aggregate of $230,400 to be paid in eight
         quarterly installments of $28,800 each.

         Euro Pacific Securities Service
         -------------------------------

         In June 1996,  the  Company  filed a lawsuit in a Florida  state  court
         against  Euro  Pacific  Securities  Service GMBH & Co., KG and Mr. Wolf
         Wiese (collectively,  the "Wiese Defendants") to collect the $1,140,000
         balance due on a promissory  note  executed by the Wiese  Defendants in
         1995 relating to a stock  subscription  receivable.  In September 1996,
         the Wiese Defendants  removed the lawsuit to the United States District
         Court for the Middle District of Florida-Orlando Division.

         In July 1997,  after  missing  the  deadline  for filing  counterclaims
         against the Company,  and without having  obtained  permission from the
         Court to do so, the Wiese  Defendants  filed a separate  lawsuit in the
         same  United  States   District  Court  against  the  Company  and  its
         LaserSight  Technologies  subsidiary.   In  their  lawsuit,  the  Wiese
         Defendants alleged against the Company breach of contract,  coercion to
         enter into a contract,  misrepresentation,  together with other charges
         and sought an unspecified  amount of monetary  damages.  On October 20,
         1997,  the  Company  filed a motion to  dismiss  the Wiese  Defendants'
         lawsuit. That motion remained pending as of January 6, 1997. Management
         believes,  based in part on the advice of the Company's  counsel,  that
         the lawsuit of the Wiese  Defendants is without  substantive  merit, is
         procedurally  flawed and should not have a material  adverse  effect on
         the Company's financial condition or results of operations.

         The  Company's  lawsuit  against  the  Wiese  Defendants  was  tried on
         December 15 and 16, 1997 and  resulted in the  issuance on December 29,

<PAGE>

         1997 of a final  judgment  in favor of the  Company  in the  amount  of
         $1,140,000,  together with interest in the amount of $526,809 and costs
         and attorneys' fees in an amount yet to be determined. The deadline for
         the Wiese  Defendants  to appeal the judgment is January 28, 1998.  The
         Company is taking steps to collect on the judgment, but there can be no
         assurance  as to whether,  when or in what amount it will be able to do
         so. Any  recovery  on the  portion  of the  judgment  representing  the
         $1,140,000 amount due on the Wiese Defendants'  promissory note will be
         credited  to  stockholders'  equity,  but will  have no  effect  on the
         Company's results of operations.

         Northern New Jersey Eye Institute
         ---------------------------------

         In October 1997, the Company  received a written  request for mediation
         and,  if  necessary,  arbitration  from the  Northern  New  Jersey  Eye
         Institute,   P.A.  ("NNJEI").  The  request  related  to  the  services
         agreement  (the  "Services   Agreement")  between  the  Company's  then
         wholly-owned subsidiary, LSI Acquisition, Inc. ("LSIA"), and NNJEI that
         was entered into as part of LSIA's  acquisition  of the assets of NNJEI
         in July 1996. The request  alleged breach of contract and fraud by LSIA
         in connection with the Services Agreement and requested  termination of
         the  Services  Agreement,  "several  hundred  thousand  dollars in lost
         income  damages," and punitive  damages in an amount to be  determined.
         The  Company  has denied  NNJEI's  allegations.  The  Company and NNJEI
         discussed a possible restructuring of the relationship between LSIA and
         NNJEI  at a  mediation  session  held  on  November  16,  1997  and  in
         subsequent correspondence,  but did not reach an agreement. Thereafter,
         the  Company  sold LSIA to Vision  Twenty-One,  Inc.  ("Vision  21") on
         December 31, 1997 in a  transaction  which was effective as of December
         1, 1997.  In  connection  with the LSIA  sale,  the  Company  agreed to
         indemnify  Vision  21  from  certain  claims  related  to the  Services
         Agreement arising before December 30, 1997. Management believes,  based
         in  part  on  the  advice  of  outside  counsel,   that  the  Company's
         indemnification  obligations  under the Services  Agreement  should not
         have a material adverse effect on the Company's  financial condition or
         results of operations.



<PAGE>




                                   SIGNATURES
                                   ----------


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  undersigned  have duly caused this  amendment to be signed on its behalf by
the undersigned thereunto duly authorized.


                                            LaserSight Incorporated




Dated:     January 9, 1998                  By:  /s/ Michael R. Farris
     -------------------------                  -----------------------
                                                Michael R. Farris,
                                                Chief Executive Officer



Dated:     January 9, 1998                  By:  /s/ Gregory L. Wilson
     -------------------------                  -----------------------
                                                Gregory L. Wilson,
                                                Chief Financial Officer